Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence

被引:9
作者
Alhasan, Bashar [1 ]
Mikeladze, Marina [1 ]
Guzhova, Irina [1 ]
Margulis, Boris [1 ]
机构
[1] Russian Acad Sci, Inst Cytol, Tikhoretsky Ave 4, St Petersburg 194064, Russia
关键词
Tumor recurrence; Dormancy; Reawakening; Autophagy; Molecular chaperones; Unfolded protein response; CELL-SURFACE GRP78; FOCAL ADHESION KINASE; BREAST-CANCER CELLS; STEM-LIKE CELLS; ENDOPLASMIC-RETICULUM STRESS; HYPOXIA-INDUCED AUTOPHAGY; GROWTH-FACTOR-BETA; HEAT-SHOCK; PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA;
D O I
10.1007/s10555-023-10085-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor recurrence is a paradoxical function of a machinery, whereby a small proportion of the cancer cell population enters a resistant, dormant state, persists long-term in this condition, and then transitions to proliferation. The dormant phenotype is typical of cancer stem cells, tumor-initiating cells, disseminated tumor cells, and drug-tolerant persisters, which all demonstrate similar or even equivalent properties. Cancer cell dormancy and its conversion to repopulation are regulated by several protein signaling systems that inhibit or induce cell proliferation and provide optimal interrelations between cancer cells and their special niche; these systems act in close connection with tumor microenvironment and immune response mechanisms. During dormancy and reawakening periods, cell proteostasis machineries, autophagy, molecular chaperones, and the unfolded protein response are recruited to protect refractory tumor cells from a wide variety of stressors and therapeutic insults. Proteostasis mechanisms functionally or even physically interfere with the main regulators of tumor relapse, and the significance of these interactions and implications in the tumor recurrence phases are discussed in this review.
引用
收藏
页码:217 / 254
页数:38
相关论文
共 388 条
  • [1] Regulation of focal adhesion kinase by a novel protein inhibitor FIP200
    Abbi, S
    Ueda, H
    Zheng, CH
    Cooper, LA
    Zhao, JH
    Christopher, R
    Guan, JL
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (09) : 3178 - 3191
  • [2] Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells
    Agarwal, Puneet
    Isringhausen, Stephan
    Li, Hui
    Paterson, Andrew J.
    He, Jianbo
    Gomariz, Alvaro
    Nagasawa, Takashi
    Nombela-Arrieta, Cesar
    Bhatia, Ravi
    [J]. CELL STEM CELL, 2019, 24 (05) : 769 - +
  • [3] Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth
    Aguirre-Ghiso, JA
    Ossowski, L
    Rosenbaum, SK
    [J]. CANCER RESEARCH, 2004, 64 (20) : 7336 - 7345
  • [4] Urokinase receptor and fibronectin regulate the ERKMAPK to p38MAPK activity ratios that determine carcinoma cell proliferation or dormancy in vivo
    Aguirre-Ghiso, JA
    Liu, D
    Mignatti, A
    Kovalski, K
    Ossowski, L
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (04) : 863 - 879
  • [5] Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684
  • [6] Translating the Science of Cancer Dormancy to the Clinic
    Aguirre-Ghiso, Julio A.
    [J]. CANCER RESEARCH, 2021, 81 (18) : 4673 - 4675
  • [7] Emerging Topics on Disseminated Cancer Cell Dormancy and the Paradigm of Metastasis
    Aguirre-Ghiso, Julio A.
    Sosa, Maria Soledad
    [J]. ANNUAL REVIEW OF CANCER BIOLOGY, VOL 2, 2018, 2 : 377 - 393
  • [8] Autophagy negatively regulates tumor cell proliferation through phosphorylation dependent degradation of the Notch1 intracellular domain
    Ahn, Ji-Seon
    Ann, Eun-Jung
    Kim, Mi-Yeon
    Yoon, Ji-Hye
    Lee, Hye-Jin
    Jo, Eun-Hye
    Lee, Keesook
    Lee, Ji Shin
    Park, Hee-Sae
    [J]. ONCOTARGET, 2016, 7 (48) : 79033 - 79049
  • [9] Autophagy and Cancer Dormancy
    Akkoc, Yunus
    Peker, Nesibe
    Akcay, Arzu
    Gozuacik, Devrim
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Reciprocal regulation between GCN2 (eIF2AK4) and PERK (eIF2AK3) through the JNK-FOXO3 axis to modulate cancer drug resistance and clonal survival
    Alasiri, Glowi
    Jiramongkol, Yannasittha
    Trakansuebkul, Sasanan
    Ke, Hui-Ling
    Mahmud, Zimam
    Intuyod, Kitti
    Lam, Eric W-F
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2020, 515